RAYTHEON CO's ticker is RTN and the CUSIP is 755111507. A total of 1,193 filers reported holding RAYTHEON CO in Q3 2017. The put-call ratio across all filers is 1.06 and the average weighting 0.4%.
About RAYTHEON CO
Raytheon Co. is a leading technology and innovation company that specializes in defense, civil government, and cybersecurity solutions. With a history spanning over 90 years, Raytheon has established itself as a trusted partner to governments and businesses around the world.
One of the key strengths of Raytheon is its focus on research and development. The company invests heavily in cutting-edge technologies and has a strong track record of delivering innovative solutions to its customers. This has helped Raytheon to stay ahead of the competition and maintain its position as a leader in the industry.
Another factor that sets Raytheon apart is its commitment to sustainability. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. This includes reducing greenhouse gas emissions, conserving water, and minimizing waste.
Despite the challenges posed by the COVID-19 pandemic, Raytheon has continued to perform well. The company reported strong financial results in the first quarter of 2021, with net sales of $15.2 billion and earnings per share of $0.90. This is a testament to the resilience of the company and its ability to adapt to changing market conditions.
Overall, Raytheon is a company that is well-positioned for long-term success. With its focus on innovation, sustainability, and strong financial performance, Raytheon is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $74,162,000 | -28.5% | 565,473 | +19.7% | 0.16% | -12.6% |
| Q4 2019 | $103,786,000 | +28.6% | 472,311 | +14.9% | 0.18% | +19.0% |
| Q3 2019 | $80,676,000 | +15.2% | 411,215 | +2.1% | 0.15% | +18.6% |
| Q2 2019 | $70,002,000 | +11.8% | 402,588 | +17.0% | 0.13% | +4.0% |
| Q1 2019 | $62,635,000 | +24.4% | 343,997 | +41.2% | 0.12% | +29.2% |
| Q3 2018 | $50,355,000 | +10.1% | 243,662 | +2.9% | 0.10% | +4.3% |
| Q2 2018 | $45,755,000 | -11.6% | 236,853 | -1.2% | 0.09% | -12.4% |
| Q1 2018 | $51,744,000 | +34.2% | 239,753 | +16.8% | 0.10% | +43.8% |
| Q4 2017 | $38,555,000 | +56.9% | 205,245 | +55.9% | 0.07% | +62.2% |
| Q3 2017 | $24,568,000 | +128.2% | 131,675 | +97.5% | 0.04% | +125.0% |
| Q2 2017 | $10,767,000 | – | 66,679 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brick & Kyle, Associates | 62,251 | $4,480 | 2.38% |
| Providence Wealth Advisors, LLC | 6,475 | $462,478 | 0.52% |
| PHYSICIANS FINANCIAL SERVICES, INC. | 14,579 | $1,049 | 0.43% |
| Shakespeare Wealth Management, LLC | 8,383 | $603,325 | 0.21% |